In U251MG cells and the primary human glioma cells (“P1/P2”), Ninj2 shRNA induced significant apoptosis activation, evidenced by increases of caspase-3 activity (Figure 5F) and TUNEL-positive nuclei ratio (Figure 5G). The gene discussed is CASP3; the disease is central nervous system cancer.